Episode 19
S02 Ep041 | Surviving Mount St. Helens + Gold Nanotech for Blindness
September 1st, 2025
58 mins
Tags
About this Episode
In Episode 41 of The Genesis Science Report, David opens with a look at recent claims of potential life on exoplanet K2-18b, where scientists have detected atmospheric compounds that on Earth are typically produced by living organisms. David explores both the excitement and the caution surrounding such discoveries, reminding us that while science uncovers fascinating possibilities, these findings ultimately point to the creativity of the Designer.
Next, filmmaker Michael Lienau shares his gripping firsthand account of surviving the 1980 Mount St. Helens eruption. Trapped in the blast zone during a second eruption, Lienau’s story is one of providence, faith, and resilience—offering a rare window into a geological event that reshaped the landscape in hours and challenged long-held assumptions about Earth’s history.
Then, physicist Dr. Jake Hebert of the Institute for Creation Research examines new Ice Age fossil discoveries that suggest parts of North America were grasslands rather than frozen wastelands. He explains how these findings fit within a post-Flood climate model and why they challenge conventional evolutionary timelines.
Finally, biologist Dr. Jerry Bergman discusses an innovative new treatment for blindness that uses gold nanoparticles to stimulate deeper retinal cells. He shows how this cutting-edge research not only offers hope for restoring vision but also highlights the incredible layers of design built into the human eye.
Also featured: a Kids Corner on volcanic ash and minerals from Mount St. Helens, a Genesis Science Minute on morality and human worth, and a Featured Resource—Replacing Darwin by Dr. Nathaniel Jeanson—offering a genetics-based model that replaces outdated evolutionary ideas.
This episode blends breaking science, history, and faith—revealing God’s handiwork in creation and His providence in life’s most powerful moments.
Support Genesis Science Report with David Rives